Keyphrases
5-year Survival
25%
Antiangiogenic Agents
25%
Antigenic Protein
25%
Antitumor Agents
25%
Apoptotic Tumor Cells
25%
Ascites
25%
Ascitic Fluid
25%
Bursa
25%
C57BL
25%
Cell Lysate
25%
Common Cancers
25%
Epithelial Cells
25%
Epithelial Ovarian Cancer
100%
Human Ovarian Cancer Cell
25%
Immunoblot Analysis
25%
Lesion Dissemination
25%
Mimetic Peptide
25%
Mitogen-activated Protein Kinase
25%
Ovarian Cancer
25%
Ovarian Tumor
100%
Overall Survival Rate
25%
Phosphoinositide 3-kinase (PI3K)
25%
Preclinical Animal Models
25%
Proliferating Cell nuclear Antigen
25%
Protein Expression
25%
Secondary Lesions
25%
Small Vessels
25%
Survival Pathways
25%
Syngeneic Model
100%
Thrombospondin-1 (TSP-1)
25%
Tissue Hypoxia
25%
Tumor
50%
Tumor Burden
25%
Tumor Cell Apoptosis
100%
Tumor Growth
100%
Tumor Size
25%
Vascular Endothelial Growth Factor
25%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
25%
Vascular Remodeling
25%
Vasculature
25%
Volume of Fluid
25%
Medicine and Dentistry
Antiangiogenic
25%
Anticarcinogen
25%
Antigen
25%
Ascites
25%
Ascites Fluid
25%
C57BL/6
25%
Cancer Cell
25%
Epithelial Cell
25%
Hypoxemia
25%
Immunoblotting
25%
In Vitro
25%
Krukenberg Tumor
100%
Malignant Neoplasm
25%
Mitogen-Activated Protein Kinase
25%
Neoplasm
75%
Ovarian Cancer
50%
Ovarian Tumor
100%
Overall Survival
25%
Phosphoinositide 3-Kinase
25%
Programmed Cell Death
100%
Proliferating Cell Nuclear Antigen
25%
Protein Expression
25%
Survival Rate
50%
Thrombospondin 1
25%
Tumor Cell
100%
Tumor Progression
100%
Vascular Remodeling
25%
Vascularity
25%
Vasculotropin
25%
Vasculotropin Receptor 2
25%
Vessel Diameter
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antiangiogenic
16%
Anticarcinogen
16%
Antigen
16%
Ascites
33%
C57BL 6 Mouse
16%
Cycline
16%
Hypoxemia
16%
Malignant Neoplasm
16%
Mitogen Activated Protein Kinase
16%
Mouse Model
16%
Neoplasm
100%
Ovary Cancer
33%
Ovary Carcinoma
100%
Ovary Tumor
100%
Overall Survival
16%
Phosphatidylinositol 3 Kinase
16%
Survival Rate
33%
Thrombospondin 1
16%
Tumor Growth
100%
Vascular Remodeling
16%
Vasculotropin
16%
Vasculotropin Receptor 2
16%
Western Blot
16%